408 related articles for article (PubMed ID: 25634603)
1. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
Ma J; Guo X; Zhang S; Liu H; Lu J; Dong Z; Liu K; Ming L
Mol Med Rep; 2015 Jun; 11(6):4525-31. PubMed ID: 25634603
[TBL] [Abstract][Full Text] [Related]
2. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
4. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
5. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
An X; Wei Z; Ran B; Tian H; Gu H; Liu Y; Cui H; Zhu S
Anticancer Agents Med Chem; 2020; 20(17):2114-2124. PubMed ID: 32593284
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
[TBL] [Abstract][Full Text] [Related]
8. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells.
Chen X; Xiao W; Chen W; Luo L; Ye S; Liu Y
Cell Death Dis; 2013 Oct; 4(10):e884. PubMed ID: 24157878
[TBL] [Abstract][Full Text] [Related]
9. Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways.
Cao J; Lv W; Wang L; Xu J; Yuan P; Huang S; He Z; Hu J
Cell Death Dis; 2018 Jul; 9(8):817. PubMed ID: 30050135
[TBL] [Abstract][Full Text] [Related]
10. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A
J Immunol; 2008 May; 180(9):5898-906. PubMed ID: 18424709
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY
Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871
[TBL] [Abstract][Full Text] [Related]
14. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
15. [Effect of downregulation of Tiam1 by siRNA on esophageal squamous cell carcinoma EC9706 cells].
Liu H; Jiang L; Liu X
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):250-6. PubMed ID: 24989909
[TBL] [Abstract][Full Text] [Related]
16. Effects of downregulation of SIRT3 expression on proliferation and apoptosis in esophageal squamous cell carcinoma EC9706 cells and its molecular mechanisms.
Yang M; Yang C; Pei Y
Biomed Mater Eng; 2014; 24(6):3883-90. PubMed ID: 25227106
[TBL] [Abstract][Full Text] [Related]
17. External Qi of Yan Xin Qigong inhibits activation of Akt, Erk1/2 and NF-ĸB and induces cell cycle arrest and apoptosis in colorectal cancer cells.
Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
Cell Physiol Biochem; 2013; 31(1):113-22. PubMed ID: 23363659
[TBL] [Abstract][Full Text] [Related]
18. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
19. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.
Herold C; Ganslmayer M; Ocker M; Hermann M; Geerts A; Hahn EG; Schuppan D
J Hepatol; 2002 Feb; 36(2):233-40. PubMed ID: 11830335
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Rad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells.
Pang X; He G; Luo C; Wang Y; Zhang B
Tumour Biol; 2016 Jan; 37(1):963-70. PubMed ID: 26264615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
